These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20456035)

  • 1. Human adenovirus-36 and non-alcoholic fatty liver disease.
    Atkinson RL
    Liver Int; 2010 Feb; 30(2):164-5. PubMed ID: 20456035
    [No Abstract]   [Full Text] [Related]  

  • 2. Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease.
    Trovato GM; Martines GF; Garozzo A; Tonzuso A; Timpanaro R; Pirri C; Trovato FM; Catalano D
    Liver Int; 2010 Feb; 30(2):184-90. PubMed ID: 19840251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-36 and obesity.
    Atkinson RL
    Pediatr Obes; 2012 Apr; 7(2):e18-9. PubMed ID: 22434760
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to 'human adenovirus-36 and childhood obesity'.
    Goossens VJ; Bruggeman CA
    Pediatr Obes; 2012 Apr; 7(2):e19-20. PubMed ID: 22434761
    [No Abstract]   [Full Text] [Related]  

  • 5. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance.
    Trovato GM; Martines GF; Trovato FM; Pirri C; Pace P; Garozzo A; Castro A; Catalano D
    Dig Dis Sci; 2012 Feb; 57(2):535-44. PubMed ID: 21953137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids.
    Atkinson RL; Dhurandhar NV; Allison DB; Bowen RL; Israel BA; Albu JB; Augustus AS
    Int J Obes (Lond); 2005 Mar; 29(3):281-6. PubMed ID: 15611785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of adenovirus 36 as a risk factor in obesity: the first clinical study made in the fatty tissues of adults in Turkey.
    Ergin S; Altan E; Pilanci O; Sirekbasan S; Cortuk O; Cizmecigil U; Ersin I; Elbey H; Dinc HO; Habip Z; Turan N; Arinci A; Richt JA; Goossens VJ; Karakullukcu A; Kocak BT; Saribas S; Koksal S; Yilmaz H; Kocazeybek B
    Microb Pathog; 2015 Mar; 80():57-62. PubMed ID: 25720551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of infection with adenovirus-36 in Belgium and Holland and association with obesity.
    Atkinson RL
    Obesity (Silver Spring); 2011 Jan; 19(1):2; author reply 3. PubMed ID: 21187841
    [No Abstract]   [Full Text] [Related]  

  • 9. ADV36 adipogenic adenovirus in human liver disease.
    Trovato FM; Catalano D; Garozzo A; Martines GF; Pirri C; Trovato GM
    World J Gastroenterol; 2014 Oct; 20(40):14706-16. PubMed ID: 25356033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of adenovirus type 14 in US military recruits--a new challenge.
    Binn LN; Sanchez JL; Gaydos JC
    J Infect Dis; 2007 Nov; 196(10):1436-7. PubMed ID: 18008220
    [No Abstract]   [Full Text] [Related]  

  • 11. Adenovirus 36 infection and obesity.
    Esposito S; Preti V; Consolo S; Nazzari E; Principi N
    J Clin Virol; 2012 Oct; 55(2):95-100. PubMed ID: 22771001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of neutralizing antibodies to adenovirus type 5 among children in India: implications for recombinant adenovirus-based vaccines.
    Appaiahgari MB; Pandey RM; Vrati S
    Clin Vaccine Immunol; 2007 Aug; 14(8):1053-5. PubMed ID: 17596429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults.
    Zhang S; Huang W; Zhou X; Zhao Q; Wang Q; Jia B
    J Med Virol; 2013 Jun; 85(6):1077-84. PubMed ID: 23588735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could viruses contribute to the worldwide epidemic of obesity?
    Atkinson RL
    Int J Pediatr Obes; 2008; 3 Suppl 1():37-43. PubMed ID: 18278631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adenoviruses as causative agents in gastroenteritis].
    de Jong JC
    Ned Tijdschr Geneeskd; 1996 Mar; 140(10):536-41. PubMed ID: 8628405
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute inflammatory response and remodeling of airway epithelium after subspecies B1 human adenovirus infection of the mouse lower respiratory tract.
    Kajon AE; Gigliotti AP; Harrod KS
    J Med Virol; 2003 Oct; 71(2):233-44. PubMed ID: 12938198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of obesity, insulin resistance, and steatosis in hepatitis C virus infection.
    Puri P; Sanyal AJ
    Clin Liver Dis; 2006 Nov; 10(4):793-819. PubMed ID: 17164118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of antibodies to adenovirus serotype 5 in an adult Indian population and implications for adenovirus vector vaccines.
    Pilankatta R; Chawla T; Khanna N; Swaminathan S
    J Med Virol; 2010 Mar; 82(3):407-14. PubMed ID: 20087930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials.
    Mast TC; Kierstead L; Gupta SB; Nikas AA; Kallas EG; Novitsky V; Mbewe B; Pitisuttithum P; Schechter M; Vardas E; Wolfe ND; Aste-Amezaga M; Casimiro DR; Coplan P; Straus WL; Shiver JW
    Vaccine; 2010 Jan; 28(4):950-7. PubMed ID: 19925902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular basis of adenovirus pathogenesis.
    Ginsberg HS; Prince GA
    Infect Agents Dis; 1994 Feb; 3(1):1-8. PubMed ID: 7952924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.